Skip to content

KYMR

Kymera Therapeutics, Inc.

Key figures

MetricLast 12 months5-year CAGR
Revenue$102M+2.9%
Gross profit$0—
Operating income−$405M—
Net income−$349M—
EPS−$3.62—
Free cash flow−$289M—